Medical technology as a key driver of rising health expenditure: disentangling the relationship.
TLDR
It is argued that decision-makers and other commentators should extend their focus beyond costs solely to include consideration of whether medical technology results in better value in health care and broader socioeconomic benefits.Abstract:
Health care spending has risen steadily in most countries, becoming a concern for decision-makers worldwide. Commentators often point to new medical technology as the key driver for burgeoning expenditures. This paper critically appraises this conjecture, based on an analysis of the existing literature, with the aim of offering a more detailed and considered analysis of this relationship. Several databases were searched to identify relevant literature. Various categories of studies (eg, multivariate and cost-effectiveness analyses) were included to cover different perspectives, methodological approaches, and issues regarding the link between medical technology and costs. Selected articles were reviewed and relevant information was extracted into a standardized template and analyzed for key cross-cutting themes, ie, impact of technology on costs, factors influencing this relationship, and methodological challenges in measuring such linkages. A total of 86 studies were reviewed. The analysis suggests that the relationship between medical technology and spending is complex and often conflicting. Findings were frequently contingent on varying factors, such as the availability of other interventions, patient population, and the methodological approach employed. Moreover, the impact of technology on costs differed across technologies, in that some (eg, cancer drugs, invasive medical devices) had significant financial implications, while others were cost-neutral or cost-saving. In light of these issues, we argue that decision-makers and other commentators should extend their focus beyond costs solely to include consideration of whether medical technology results in better value in health care and broader socioeconomic benefits.read more
Citations
More filters
Journal ArticleDOI
The National Bureau of Economic Research
TL;DR: The National Bureau of Economic Research (NBRE) as mentioned in this paper is a private non-profit corporation, formed to conduct or assist in the making of exact and impartial investigations in the field of economic, social and industrial science, and to this end to cooperate with governments, universities, learned societies, and individuals.
Journal ArticleDOI
Advantages and disadvantages of 3-dimensional printing in surgery: A systematic review.
Nicolas Martelli,Carole Serrano,Hélène van den Brink,Judith Pineau,Patrice Prognon,Isabelle Borget,Salma El Batti +6 more
TL;DR: The development of guidelines to improve the reporting of experience with 3D printing in surgery is highly desirable and the additional cost and the time needed to produce devices by current 3D technology still limit its widespread use in hospitals.
Journal ArticleDOI
Evolution and patterns of global health financing 1995–2014: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries
Joseph L Dieleman,Madeline Campbell,Abigail Chapin,Erika Eldrenkamp,Victoria Y. Fan,Annie Haakenstad,Jennifer Kates,Yingying Liu,Taylor Matyasz,Angela E Micah,Alex Reynolds,Nafis Sadat,Matthew T. Schneider,Reed J D Sorensen,Tim S. Evans,David M. Evans,Christoph Kurowski,Ajay Tandon,Kaja Abbas,Semaw Ferede Abera,Aliasghar Ahmad Kiadaliri,Kedir Y. Ahmed,Muktar Beshir Ahmed,Khurshid Alam,Reza Alizadeh-Navaei,Ala'a Alkerwi,Erfan Amini,Walid Ammar,Stephen M. Amrock,Carl Abelardo T. Antonio,Tesfay Mehari Atey,Leticia Avila-Burgos,Ashish Awasthi,Aleksandra Barac,Oscar Bernal,Addisu Shunu Beyene,Tariku Jibat Beyene,Charles Birungi,Habtamu Mellie Bizuayehu,Nicholas J K Breitborde,Lucero Cahuana-Hurtado,Ruben Castro,Ferran Catalia-Lopez,Koustuv Dalal,Lalit Dandona,Rakhi Dandona,Pieter de Jager,Samath D Dharmaratne,Manisha Dubey,Carla Sofia e Sa Farinha,André Faro,Andrea B. Feigl,Florian Fischer,Joseph R Fitchett,Nataliya Foigt,Ababi Zergaw Giref,Rashmi Gupta,Samer Hamidi,Hilda L Harb,Simon I. Hay,Delia Hendrie,Masako Horino,Mikk Jürisson,Mihajlo Jakovljevic,Mehdi Javanbakht,Denny John,Jost B. Jonas,Seyed M Karimi,Young-Ho Khang,Jagdish Khubchandani,Yun Jin Kim,Jonas Minet Kinge,Kristopher J Krohn,G Anil Kumar,Hassan Magdy Abd El Razek,Mohammed Magdy Abd El Razek,Azeem Majeed,Reza Malekzadeh,Felix Masiye,Toni Meier,Atte Meretoja,Ted R. Miller,Erkin M. Mirrakhimov,Shafiu Mohammed,Vinay Nangia,Stefano Olgiati,Abdalla Sidahmed Osman,Mayowa O. Owolabi,Tejas Patel,Angel J Paternina Caicedo,David M. Pereira,Julian Perelman,Suzanne Polinder,Anwar Rafay,Vafa Rahimi-Movaghar,Rajesh Kumar Rai,Usha Ram,Chhabi Lal Ranabhat,Hirbo Shore Roba,Joseph Salama,Miloje Savic,Sadaf G. Sepanlou,Mark G. Shrime,Roberto Tchio Talongwa,Braden Te Ao,Fabrizio Tediosi,Azeb Gebresilassie Tesema,Alan J Thomson,Ruoyan Tobe-Gai,Roman Topor-Madry,Eduardo A. Undurraga,Tommi Vasankari,Francesco Saverio Violante,Andrea Werdecker,Tissa Wijeratne,Gelin Xu,Naohiro Yonemoto,Mustafa Z. Younis,Chuanhua Yu,Zoubida Zaidi,Maysaa El Sayed Zaki,Christopher J L Murray +121 more
TL;DR: Health spending remains disparate, with low-income and lower-middle-income countries increasing spending in absolute terms the least, and relying heavily on OOP spending and development assistance.
Journal ArticleDOI
The Health Financing Transition: A Conceptual Framework and Empirical Evidence
TL;DR: Use of data over 1995-2009 from 126 countries shows a significant trend in health spending - rising about 1 per cent annually - which is associated with a combination of changing technology and medical practices, cost pressures and institutions that finance and manage healthcare.
Journal ArticleDOI
Priority-setting for achieving universal health coverage
Kalipso Chalkidou,Amanda Glassman,Robert Marten,Jeanette Vega,Yot Teerawattananon,Nattha Tritasavit,Martha Gyansa-Lutterodt,Andreas Seiter,Marie Paule Kieny,Karen Hofman,Anthony J. Culyer +10 more
TL;DR: In this article, the authors provide justification for explicit health priority-setting and guidance to countries on how to set priorities for universal health coverage (UHC) in low and middle-income countries.
References
More filters
Journal ArticleDOI
Medical care costs: how much welfare loss?
TL;DR: This article focuses mainly on costs, arguing that the issue has been somewhat misconceived: while the level of medical care spending in the U.S. is a cause for concern, the welfare losses associated with rises in that level of spending may not be as large as the public rhetoric can make them seem.
Journal ArticleDOI
Is Technological Change In Medicine Worth It
David M. Cutler,Mark McClellan +1 more
TL;DR: It is concluded that medical spending as a whole is worth the increased cost of care, and has many implications for public policy.
Journal ArticleDOI
The Value of Life and the Rise in Health Spending
Robert E. Hall,Charles I. Jones +1 more
TL;DR: In this article, the authors developed a model based on standard economic assumptions and argued that health spending is a superior good with an income elasticity well above one, and that the optimal composition of total spending shifts toward health, and the health share grows along with income.
Journal ArticleDOI
Trends in Medicare Payments in the Last Year of Life
James Lubitz,Gerald F. Riley +1 more
TL;DR: There is no evidence that persons in the last year of life account for a larger share of Medicare expenditures than in earlier years, and the same forces that have acted to increase overall Medicare expenditures have affected care for both decedents and survivors.
Posted Content
The Health Care Quadrilemma: An Essay on Technological Change, Insurance, Quality of Care, and Cost Containment
TL;DR: For example, this article showed that only 25% of the 200 top-selling drugs in 1972 remained in the group 15 years later (David Cleeton, Valy Goepfrich, and Burton Weisbrod 1990).